Scarica l'app Stockscreener
40.94
1.61%
-0.67
Dopo l'orario di chiusura:
40.94
Precedente Chiudi:
$41.61
Aprire:
$41.34
Volume 24 ore:
372.20K
Relative Volume:
0.39
Capitalizzazione di mercato:
$3.30B
Reddito:
-
Utile/perdita netta:
$-64.16M
Rapporto P/E:
-32.23
EPS:
-1.2702
Flusso di cassa netto:
$-69.06M
1 W Prestazione:
-5.45%
1M Prestazione:
+3.88%
6M Prestazione:
+54.49%
1 anno Prestazione:
+41.81%
Intervallo 1D:
$40.83
$42.40
Intervallo di 1 settimana:
$40.43
$44.01
Portata 52W:
$14.80
$46.01
Cg Oncology Inc Stock (CGON) Company Profile
Nome
Cg Oncology Inc
Settore
Industria
Telefono
(949) 419-6203
Indirizzo
400 SPECTRUM CENTER DRIVE, IRVINE
Confronta CGON con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
40.94 | 3.36B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-24 | Iniziato | Truist | Buy |
| 2025-10-08 | Iniziato | Guggenheim | Buy |
| 2025-08-19 | Iniziato | Piper Sandler | Overweight |
| 2025-07-10 | Ripresa | Goldman | Buy |
| 2025-05-02 | Iniziato | JP Morgan | Overweight |
| 2025-04-16 | Iniziato | Scotiabank | Sector Perform |
| 2025-01-07 | Iniziato | TD Cowen | Buy |
| 2024-10-24 | Iniziato | UBS | Buy |
| 2024-09-23 | Iniziato | RBC Capital Mkts | Outperform |
| 2024-08-28 | Iniziato | ROTH MKM | Buy |
| 2024-06-28 | Iniziato | BofA Securities | Buy |
| 2024-02-20 | Iniziato | Cantor Fitzgerald | Overweight |
| 2024-02-20 | Iniziato | Goldman | Neutral |
| 2024-02-20 | Iniziato | Morgan Stanley | Overweight |
| 2024-02-14 | Iniziato | H.C. Wainwright | Buy |
Mostra tutto
Cg Oncology Inc Borsa (CGON) Ultime notizie
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Purchases Shares of 26,000 CG Oncology, Inc. $CGON - MarketBeat
CG Oncology (NASDAQ:CGON) Earns Outperform Rating from Analysts at Wedbush - MarketBeat
CG Oncology initiated with an Outperform at Wedbush - TipRanks
How Positive Cretostimogene Trial Updates And Leadership Moves At CG Oncology (CGON) Have Changed Its Investment Story - Yahoo Finance
CG Oncology, Inc. (CGON) is a Buy on Cancer Treatment Development: Truist Securities - Insider Monkey
CG Oncology (CGON) Valuation Check After Strong Late-Breaking Cretostimogene Bladder Cancer Trial Results - Sahm
Promising Prospects for CG Oncology, Inc.: Buy Rating Backed by Cretostimogene’s Potential in NMIBC Market - TipRanks
CG Oncology (NASDAQ:CGON) Sets New 1-Year HighStill a Buy? - MarketBeat
Cg Oncology Inc. (CGON) Live Share Price, Invest From India - INDmoney
CG Oncology, Inc. (CGON) stock price, news, quote and history - Yahoo Finance UK
CG Oncology Incannounced topline data from Bond-003 cohort P and first results from Core-008 cohort A - marketscreener.com
New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer - The Manila Times
CG Oncology Reports Promising Efficacy and Safety Data for Cretostimogene in High-Risk Non-Muscle Invasive Bladder Cancer Trials - Quiver Quantitative
CG Oncology (NASDAQ: CGON) posts 83.7% CR, no Grade 3+ AEs in NMIBC trial data - Stock Titan
Schroder Investment Management Group Acquires 155,737 Shares of CG Oncology, Inc. $CGON - MarketBeat
CG Oncology appoints Rossi to its Board of Directors - MSN
Will CG Oncology’s (CGON) Board Refresh and Cretostimogene Data Shape Its Bladder Cancer Strategy? - Sahm
Muscle Invasive Bladder Cancer Market to Reach New Heights - openPR.com
Midday Stock Roundup: Tilly’s, indie Semiconductor Up - Orange County Business Journal
CG Oncology (CGON) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
FY2025 EPS Estimates for CG Oncology Increased by Analyst - MarketBeat
A Look at CG Oncology's (CGON) Valuation Following New Clinical Trial Data Announcements - Sahm
Will CG Oncology Inc. stock beat EPS estimatesMarket Sentiment Review & Proven Capital Preservation Tips - BỘ NỘI VỤ
Guidance Update: Will CG Oncology Inc. stock beat EPS estimates2025 Key Lessons & Proven Capital Preservation Tips - moha.gov.vn
Tejara Capital Ltd Purchases New Position in CG Oncology, Inc. $CGON - MarketBeat
Midday Stock Roundup: Eledon Up 4.8% - Orange County Business Journal
Intech Investment Management LLC Acquires 6,503 Shares of CG Oncology, Inc. $CGON - MarketBeat
CG Oncology, Inc. $CGON Shares Purchased by Franklin Resources Inc. - MarketBeat
Geode Capital Management LLC Increases Stake in CG Oncology, Inc. $CGON - MarketBeat
CG Oncology Appoints Christina Rossi to Board - MSN
Why analysts upgrade CG Oncology Inc. stock2025 Analyst Calls & Long-Term Growth Stock Strategies - moha.gov.vn
CG Oncology (NASDAQ:CGON) Reaches New 12-Month HighHere's What Happened - MarketBeat
[Form 4] CG Oncology, Inc. Insider Trading Activity - Stock Titan
[Form 3] CG Oncology, Inc. Initial Statement of Beneficial Ownership - Stock Titan
CG Oncology, Inc. Announces Board and Committee Changes - marketscreener.com
CG Oncology appoints Christina Rossi to board of directors By Investing.com - Investing.com Nigeria
Promising Developments in CG Oncology’s NMIBC Treatment Drive Buy Recommendation - TipRanks
CG Oncology appoints Christina Rossi to board as Simone Song resigns - Investing.com UK
CG Oncology appoints Christina Rossi to board as Simone Song resigns By Investing.com - Investing.com South Africa
CG Oncology appoints Christina Rossi to board of directors - Investing.com India
CG Oncology Announces Board Changes - TradingView
[8-K] CG Oncology, Inc. Reports Material Event | CGON SEC FilingForm 8-K - Stock Titan
CG Oncology Appoints Christina Rossi to Board of Directors - Quiver Quantitative
CG Oncology Announces New Board Member and Board Transition - The Manila Times
CG Oncology (NASDAQ: CGON) names Rossi to board amid BLA initiation - Stock Titan
CG Oncology, Inc. $CGON Position Lifted by Foresite Capital Management V LLC - MarketBeat
CG Oncology (NASDAQ: CGON) highlights BOND-003 and CORE-008 NMIBC data at SUO meeting - Stock Titan
Truist Financial Begins Coverage on CG Oncology (NASDAQ:CGON) - MarketBeat
CG Oncology, Inc. (CGON) Has a New Rating from Truist Financial - The Globe and Mail
CG Oncology Inc Stock Analysis and ForecastVolume Profile Analysis & Explosive Profit Growth - earlytimes.in
TD Cowen Initiates Coverage of CG Oncology (CGON) with Buy Recommendation - MSN
Cg Oncology Inc Azioni (CGON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.08%
0.91%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):